The utility of naphthyl-keratin adducts as biomarkers for jet-fuel exposure by Kang-Sickel, Juei-Chuan et al.
The utility of naphthyl-keratin adducts as biomarkers for jet-fuel
exposure
Juei-Chuan C. Kang-Sickel1, Mary Ann Butler2, Lynn Frame3, Berrin Serdar4, Yi-Chun E.
Chao1, Peter Egeghy5, Stephen M. Rappaport6, Christine A. Toennis2, Wang Li7, Tatyana
Borisova3, John E. French8, and Leena A. Nylander-French1
1Department of Environmental Sciences and Engineering, Gillings School of Global Public Health,
The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
2Division of Applied Research and Technology, National Institute for Occupational Safety and
Health, Centers for Disease Control and Prevention, Cincinnati, OH, USA
3Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences
Center, Lubbock, TX, USA
4Department of Environmental and Occupational Health, Colorado School of Public Health,
University of Colorado Denver, Aurora, Colorado, USA
5US Environmental Protection Agency, National Exposure Research Laboratory, Human
Exposure and Atmospheric Sciences Division, Research Triangle Park, NC, USA
6School of Public Health, University of California, Berkeley, CA, USA
7Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX,
USA
8Host Susceptibility Branch, National Toxicology Program, The National Institute of Environmental
Health Sciences, Research Triangle Park, NC, USA
Abstract
We investigated the association between biomarkers of dermal exposure, naphthyl-keratin adducts
(NKA), and urine naphthalene biomarker levels in 105 workers routinely exposed to jet-fuel. A
moderate correlation was observed between NKA and urine naphthalene levels (p = 0.061). The
NKA, post-exposure breath naphthalene, and male gender were associated with an increase, while
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CYP2E1*6 DD and GSTT1-plus (++/+−) genotypes were associated with a decrease in urine
naphthalene level (p < 0.0001). The NKA show great promise as biomarkers for dermal exposure
to naphthalene. Further studies are warranted to characterize the relationship between NKA, other
exposure biomarkers, and/or biomarkers of biological effects due to naphthalene and/or PAH
exposure.
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Introduction
Jet propulsion fuels (kerosene-based fuel mixtures) are standard fuels for commercial
aviation as well as for military aircrafts and vehicles. Jet propulsion fuel type 8 (JP-8) is the
battle field fuel for all U.S. military operations and was chosen to replace its predecessor
JP-4 in 1972 by North Atlantic Treaty Organization (NATO) due to its higher flashpoint
(ATSDR 1998; Zeiger & Smith 1998; Carlton & Smith 2000; NRC 2003). In addition, JP-8
is used as a degreaser, heat source, and cooking fuel by the U.S. military. It is estimated that
5 billion gallons of JP-8 is used by the U.S. military and NATO each year (NRC 2003). It
has been recognized as the single largest source of chemical exposure for the military
personnel (Carlton & Smith 2000). Dermal exposure to jet fuel, along with inhalation
exposure, was observed to contribute significantly to body burden in the U.S. Air Force
(USAF) fuel-cell maintenance workers (Chao et al. 2006; Kim et al. 2007). In addition, due
to its low vapor pressure and slower evaporation rate in comparison to its predecessor JP-4,
increased duration of dermal contact with JP-8 presents increased risk for dermal exposure
(Chao et al. 2005). Although JP-8 contains hundreds of aliphatic and aromatic hydrocarbons,
naphthalene and its metabolites (1- and 2-naphthol) in urine have been established as
effective surrogate biomarkers of exposure to JP-8 (Egeghy et al. 2003; Serdar et al. 2003;
Serdar et al. 2004; Chao et al. 2006; Kim et al. 2007).
Accurate quantification of the contribution of dermal exposure to the systemic dose is
required in order to complement and improve current exposure assessment models for long-
term health effects of jet fuel exposure, a facet that is missing from current epidemiological
research. Quantitation of the individual dermal dose and determination of the mechanism of
action hinges upon development of biomarkers that can encompass both acute and chronic
exposure and upon development of specific analytical procedures to quantitate these
biomarkers. The only method for quantitation of dermal exposure to jet fuel (JP-8) reported
to date measures the unmetabolized naphthalene (surrogate for JP-8) on the skin surface,
which can only be attributed to recent exposure because of rapid absorption and
biotransformation of naphthalene (Chao et al. 2005; Chao et al. 2006). Naphthalene
metabolites bound to skin keratins would be appropriate as specific biomarkers for dermal
exposure, as the bioactivation required for naphthalene metabolite adduction to keratin only
occurs in the suprabasal layer of the epidermis (Kang-Sickel et al. 2008; Kang-Sickel et al.
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2010), where keratin is synthesized de novo and the non-living squame is formed (Watt
1988). Approximately 20–28 days are required for differentiation and maturation of
suprabasal keratinocytes (Junqueira & Carneiro 2005; Furukawa et al. 2008) to migrate from
the basal layer to the surface to form the stratum corneum, which requires continuous
replacement. Therefore, non-invasive sampling of stratum corneum by sequential tape-
stripping can be used to monitor an individual’s past (< 28 days) exposure to naphthalene-
containing mixtures and characterize individual variation in dermal metabolic capacity and
keratin adduction in human populations.
The potential contribution of dermal exposure to total JP-8 exposure is suggested based on
the correlation between the metabolite levels in urine (e.g. 1- and 2-naphthol) and various
surrogates of dermal exposure, including skin irritation, work inside the fuel cell, and
removing and cleaning fuel puddles (Egeghy et al. 2003; Serdar et al. 2004). However, these
surrogate indicators provide only qualitative, not quantitative, information. We previously
established that naphthalene (as a model polycyclic aromatic hydrocarbon) and its
metabolites 1-naphthol (1NAP) and 2-naphthol (2NAP) in urine can be used as quantitative
biomarkers of a complex jet fuel mixture exposure to the skin (Chao et al. 2006). We further
established that dermal exposure to jet fuel, along with inhalation exposure, contributes
significantly to the total body burden in the exposed USAF fuel-cell maintenance workers
(Chao et al. 2005; Chao et al. 2006; Kim et al. 2007). We have also shown that highly
specific polyclonal antibodies to naphthalene metabolites can be used for a sensitive
enzyme-linked immunosorbent assay (ELISA) for quantification of NKAs as biomarkers of
dermal exposure to jet fuel (Kang-Sickel et al. 2008; Kang-Sickel et al. 2010). In dermal
tape-strip samples collected from 105 individuals exposed to JP-8, naphthyl-conjugated
keratin peptides were detected at levels from 0.004 to 6.104 pmol adduct/μg keratin, but
were undetectable in unexposed volunteers (Kang-Sickel et al. 2008; Kang-Sickel et al.
2010).
Our first objective was to characterize the association between biomarkers of dermal
exposure (i.e., NKAs) and urine naphthalene and naphthalene metabolite levels in 105 fuel-
cell maintenance workers along with inhalation exposure as well as individual and work
place factors that may contribute to these biomarker levels using multiple linear regression
models. However, naphthalene and its metabolites are substrates for biotransformation
enzymes, including cytochrome P-450s (CYPs), glutathione-S-transferases (GSTs), and
NAD(P)H:quinone oxidoreductases (NQO1) (Buckpitt et al. 2002; Preuss et al. 2003;
Waidyanatha et al. 2004a). Genetic polymorphisms account for interindividual differences
in the expression of these enzymes and, thus, may contribute to the differences in biomarker
levels and exposure-related toxicity. In the skin, as in the liver, metabolizing enzymes
convert naphthalene to more polar metabolites but also catalyze the synthesis of reactive
metabolites that bind to nucleophilic macromolecule (protein or DNA) to form adducts
(Ross & Nesnow 1993; Isbell et al. 2005; Shimada 2006; Saeed et al. 2009). Therefore, our
second objective was to examine the potential contribution of genetic variants of four genes
(CYP2E1, GSTM1, GSTT1, and NQO1), which code for biotransformation enzymes intrinsic
to naphthalene metabolism, to the observed levels of NKAs and urine biomarkers in this
worker population.
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Exposure data were available from the broad exposure assessment and health effects study
of the personnel exposed to JP-8 at six USAF bases in the continental United States
(described in Egeghy et al. 2003; Chao et al. 2005; Chao et al. 2006). While 339 USAF
personnel were enrolled in the overall study, 105 fuel-cell maintenance workers from five
bases who were monitored for both dermal and systemic levels were included in this study.
These workers serviced primarily F-series fighter jets or C-130 transporter jets. The workers
comprised of 98 males (93.3%) and 7 females (6.7%), 92 Caucasians (87.6%), and 13 non-
Caucasians (African-American, Hispanic, or Asian; 12.4%), and 46 were smokers (43.8%).
The average age of the workers was 24.7 ± 5.0 years and ranged from18 to 40 years.
Workers were recruited with informed consent from active duty USAF personnel who
routinely worked with and were exposed to JP-8. This study was approved by the
institutional review board of each of the participating investigators and for the USAF, and
the study complied with all applicable U.S. requirements and regulations.
Questionnaires and work diaries were recorded after the work shift to obtain detailed
information on demographic factors including age, ethnicity, gender, smoking status, job
tasks and durations, use of personal protective equipment (PPE), and other work-related
characteristics. Each of the workers had been assigned a priori into one of three exposure
categories (high, moderate, low) based on the primary job tasks (Chao et al. 2005). Workers
who entered fuel tanks (entrants) on the sampling day were classified as high-exposure
group. The medium-exposure group consisted of workers who were attendants and/or
runners assisting the entrants. Other field workers who had occasional contact with JP-8
were classified as the low-exposure group (Chao et al. 2005).
Collection and analyses for skin, inhalation, and urine samples
The collection of dermal tape-strip samples and analysis for naphthalene (Chao et al. 2005)
and four NKA levels (Kang-Sickel et al. 2008; Kang-Sickel et al. 2010) have been described
previously. Briefly, tape-strip samples were collected post-exposure using three sequential
adhesive tape-strips in each site (2.5 cm × 4.0 cm, surface area 10 cm2; Cover-Roll™ tape,
Beiersdorf AG, Germany) from three exposed body regions with potentially the greatest
JP-8 exposure, as identified by the subject and confirmed via visual inspection by the
investigators. In each site, side-by-side samples were collected, one set for determination of
naphthalene level and the other set for determination of NKA level. Each tape was applied
onto the skin surface with a constant pressure and removed at an approximately 45° angle
after 1 min. For determination of naphthalene level, tape was folded and placed into a
labeled scintillation vial containing 5 ml acetone and 20 μL of 25 μg/mL naphthalene-d8
(internal standard) and stored at −80°C until analysis by gas chromatography-mass
spectrometry (GC-MS). For determination of NKAs, tape was rolled with the adhesive side
facing out and placed into a 2 mL cryovial and stored at −80°C until the keratin from the
tape sample was extracted and quantified by Bradford assay and four NKAs (1-naphthyl-
keratin-1, 2-naphthyl-keratin-1, 1-naphthyl-keratin-10, and 2-naphthyl-keratin-10)
quantified by ELISA (Kang-Sickel et al. 2008).
Kang-Sickel et al. Page 4






















Inhalation exposure to naphthalene was monitored during the 4 h work shift using passive
monitors attached to the workers’ collars. End-exhaled breath samples were collected before
and immediately after the work shift using 75 cm3 glass bulbs. The full-face supplied-air
respirator was worn by 69 (100%) of the a priori high-exposure group workers, while 10
(59%) of medium-exposure and none of the low-exposure workers wore a respirator. Both
breathing-zone air and breath samples were analyzed by thermal desorption followed by GC
with photo-ionization detection, as described elsewhere (Egeghy et al. 2003). The collection
of urine samples was performed before and after the work shift and the concentrations of the
urine 1NAP and 2NAP were determined by GC-MS, as described elsewhere (Serdar et al.
2003).
Genotyping for candidate genes
A sample of whole blood was collected into a 10 mL EDTA tube (Vacutainer©; Beckton-
Dickinson and Company, Franklin Lakes, NJ, USA) for each worker at the beginning and at
the end of the work shift. The samples were packed with Blue Ice© (Rubbermaid, Atlanta,
GA, USA) and shipped to arrive at the lab within 24 h at a temperature of 4°C. Genomic
DNA was isolated from nucleated blood cells for genotyping from 0.4 mL of whole blood
using InstaGene Genomic DNA Kit (Cat #732-6028, BioRad, Hercules, CA, USA). When
additional DNA was needed for genotyping, genomic DNA was isolated from 0.3 mL of
whole blood that had been stored at −70°C using Gentra Puregene Blood Kit (Qiagen
Sciences, Inc., Germantown, MD, USA) following the manufacturers procedures.
The CYP2E1 DraI (mutant allele: CYP2E*6) restriction fragment length polymorphism was
identified by minor modifications of methods described by Kato et al. (1995). Minor
modifications of the CYP2E1 methods included using AmpliTaq Gold Polymerase and
Applied Biosystems polymerase chain reaction (PCR) Buffer II in the reaction mixture and a
10 min preincubation of the reaction mixture at 95°C prior to beginning of the specified
amplification program. The PCR amplification and restriction products were examined on
2% agarose E-gels (Invitrogen Life Technologies, Carlsbad, CA, USA) or 2% agarose gels
prepared in the laboratory containing ethidium bromide and visualized on an ultraviolet
transilluminator. The CYP2E1 has a polymorphic DraI restriction site in intron six. The
DraI restriction site is present in the CYP2E1 DraI Type D genotype, whereas the site is
missing in the CYP2E1 DraI Type C genotype.
The GSTM1 genotyping was based on the method of Huang et al. (1997). The PCR reaction
mixture contained thermophilic DNA polymerase 10X buffer with 15 mM MgCl2, 2.5 pmol
of each dNTP primer, 20 μM of each GSTM1 primer, 20 μM of each β-globin primer, 2.75
μL Taq polymerase, and 2 μL of DNA template (100–300 ng) in a total reaction volume of
50 μL. The reaction mixture was placed in a thermocycler (model PTC-100, MJ Research
Inc., Waltham, MA, USA) for 30 cycles at 95°C for 30 s followed by 45 s at 56°C, 72°C for
45 s, and a final step at 72°C for 10 min. The PCR products were separated by
electrophoresis on 2.5% agarose gels containing ethidium bromide and visualized on an
ultraviolet transilluminator. The β-globin gene served as an internal control and generated a
100 bp PCR product in all reaction tubes. Only genomic DNA from GST-positive
individuals served as a template for amplification of an additional 273 bp product.
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The GSTT1 genotype was identified using primers described by Hirvonen et al. (1996). The
PCR reaction mixture contained 1X Applied Biosystems PCR Buffer II, 2 mM MgCl2, 2.5
pmol of each dNTP primer, 30 pmol of GSTT1 primer, 10 pmol of each β-globin primer, 1
unit AmpliTaq Gold Polymerase, and 2 μL of DNA extract in a total reaction mixture of 30
μL. The reaction mixture was placed in a thermocycler (model PTC-100, MJ Research Inc.,
Waltham, MA, USA) for 10 min at 95°C followed by 25 cycles of 94°C for 1 min, 59°C for
1 min, 72°C for 1.5 min, and a final step of 72°C for 5 min. The PCR products were
examined as described for CYP2E1 above. The β-globin gene served as an internal control
and generated a 100 bp PCR product in all reaction tubes. The GSTT1-null individuals were
identified by their DNA templates that produced no amplification with GSTT1 specific
primer.
The method described by Wiemels et al. (1999), with minor modifications, was used to
characterize the single nucleotide polymorphism rs1800566 in NQO1. Minor modifications
in the NQO1 methods and examination of PCR amplification and restriction products were
carried out as described for CYP2E1 above. This genetic variant has a C to T transition in
nucleotide 609 in exon 6 of NQO1 (Guha et al. 2008).
Duplicate reactions for all genotypes were conducted on a minimum of 20% of the
participants and all duplicate results were in complete concordance.
Statistical analyses
All statistical analyses were conducted using the SAS software (Version 9.1.3, SAS
Institute, Cary, NC, USA) at a significance level of 0.10. All exposure and biomarker data
(NKA levels, dermal, breathing-zone air, and breath naphthalene levels, as well as urine
naphthalene and naphthol levels) were natural log-transformed to satisfy normality
assumptions prior to statistical analyses. All statistical models were constructed and analyses
conducted based on subjects with available data points; therefore, the sample sizes in these
analyses differed due to missing values of independent variables.
The total NKA level for each worker was calculated by summing the four keratin-
normalized adduct levels measured in all sampling sites. Pearson correlation was examined
between the total NKA level and JP-8 exposure measures (i.e. dermal, breathing-zone, pre-
and post-exposure breath naphthalene levels) and urine biomarkers [i.e. naphthalene, 1NAP,
2NAP, and total naphthol (TNAP = 1NAP + 2NAP) levels]. Analysis of variance (ANOVA)
with the significance level of 0.1 was performed to test the effects of genetic variants in four
metabolic genes (CYP2E1, GSTM1, GSTT1, and NQO1), which have been indicated in
naphthalene metabolism (Tingle & Park 1993; Wilson et al. 1996; Yang et al. 1999; Lee et
al. 2001), on the levels of total NKAs and urine biomarkers observed in this worker
population.
Multiple linear-regression analyses were conducted to examine workplace and personal
factors contributing to total NKA levels in all workers and in a priori determined high-
exposure group upon jet fuel exposure. Stepwise variable selection was used to determine
final regression models, with α = 0.10 as the inclusion level for predictors. The basic
multiple linear regression model was as follows:
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where Yi is the natural log-transformed total NKA level measured in the ith worker’s tape-
strip samples; α is the intercept; Xij represents the ith worker’s jth dermal naphthalene level;
Cik represents the kth covariate value for the ith worker based on work diary and
questionnaire, including exposure duration, job task, PPE, age, gender, and smoking status,
as well as metabolic genotypes CYP2E1, GSTM1, GSTT1, and NQO1.
A second multiple linear regression analysis was used to investigate the relationship
between the urine biomarkers and the total NKA levels as well as the contribution of the
covariates also analyzed in model 1. Again, the models were constructed separately for all
workers and for the a priori determined high-exposure group only. The basic multiple linear
regression model was as follows:
(2)
where Yi is the natural log-transformed urine biomarker level, measured in the ith worker’s
urine samples; α is the intercept; Xij represents the ith worker’s jth total NKA level; Cik
represents the kth covariate value for the ith worker, which included exposure data, PPE,
metabolic genotypes CYP2E1, GSTM1, GSTT1, and NQO1, age, ethnicity, gender, and
smoking status. Collinearity was examined for all models using variance inflation, condition
indices, and eigenvalues. Possible outliers were examined by studentized residuals.
Results
No significant correlation was observed between the total NKA levels and various exposure
measures (i.e. dermal, breath, and breathing-zone naphthalene levels) or with the urine
1NAP, 2NAP, or TNAP levels with the exception of urine naphthalene level (Pearson
correlation r = 0.184, p = 0.061) (Table 1).
The association between biomarker levels (i.e. total NKA level and urine 1NAP, 2NAP,
TNAP, or naphthalene level) and the genotype of each of the four genes (CYP2E1, GSTM1,
GSTT1, and NQO1) are presented in Table 2. A significant difference in total NKA level
was observed between individuals with GSTT1-null genotype and those with at least one
copy of GSTT1 gene [GSTT1-plus (++/+−)] (p = 0.080). Individuals carrying NQO1
homozygous variant (TT) also had significantly lower keratin adduct levels than those with
homozygous wild-type (CC) (p = 0.085).
The regression analysis showed that total NKA level was influenced by dermal naphthalene
level (lndermal), duration of exposure on the sampling day (exposure duration), and age
(Table 3). The dermal naphthalene level and the age of the worker were inversely associated
with total NKA level, while exposure duration increased total NKA levels. When we
investigated the factors related to workers assigned into the a priori high-exposure group
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only (n = 68), these same three predictors as for all workers were observed to be significant
(Table 3). None of the four metabolic genotypes were observed to be significantly
associated with total NKA level in either multiple linear-regression analysis when other
significant covariates were included in the models.
Based on the Pearson correlation results (Table 1), a second regression model was
constructed using urine naphthalene as the outcome variable. The significant predictors for
urine naphthalene levels were total NKA level, post-exposure breath naphthalene level
(lnpost-breath), CYP2E1*6 DD (wild type) genotype, presence of one or both copies of
GSTT1 gene (++/+−), and gender (Table 4). The total NKA level, post-exposure breath
naphthalene level, and male gender were associated with an increase in the urine
naphthalene level, while the CYP2E1*6 DD genotype and the presence of one or both copies
of GSTT1 gene (++/+−) were associated with a decrease in urine naphthalene level. When
this analysis was limited to the workers in the a priori high-exposure group (n = 64), 24.5%
of the total variance in the urine naphthalene level was explained by the total NKA and post-
exposure breath naphthalene levels as well as presence of GSTT1 genotype.
Discussion
Previously, we demonstrated the human skin’s capacity to express enzymes for xenobiotic
metabolism and to form NKAs in response to naphthalene exposure (Kang-Sickel et al.
2008; Kang-Sickel et al. 2010). We also demonstrated that these adducts can be
quantitatively measured in the exposed skin of workers, facilitating naphthalene exposure
assessment, particularly in regard to the dermal route (Kang-Sickel et al. 2008; Kang-Sickel
et al. 2010). In addition, inhalation and dermal exposure were identified as significant
factors contributing to the total systemic dose of naphthalene, measured as urine naphthol
levels, in workers exposed to jet fuel (Serdar et al. 2004; Chao et al. 2006; Kim et al. 2007).
Similarly, urine naphthalene was identified as a biomarker for both dermal and inhalation
exposure to polycyclic aromatic hydrocarbons (PAHs) (Campo et al. 2009; Sobus et al.
2009a; Sobus et al. 2009b).
Here, we examined the relationship between the total skin NKA levels and urine biomarkers
of naphthalene exposure, as a surrogate for JP-8 exposure. We observed a significant
correlation between total NKA and urine naphthalene levels (r = 0.184, p = 0.061) but not
between total NKA and breath naphthalene or urine naphthol levels. Jet fuel workers who
entered and worked in the fuel tanks were equipped with in-line respirators and cotton
coveralls. In this study, 75% of the fuel-cell maintenance workers (79/105) wore full-face
supplied-air respirators. Thus, the principal route of contact and exposure to naphthalene is
expected to be dermal. The NKA in the skin are formed via metabolism in the suprabasal
layer of the skin (Kang-Sickel et al. 2010) and manifested after the processes of keratinocyte
maturation, proliferation, differentiation, and migration to the surface of stratum corneum,
which take approximately 28 days (Junqueira & Carneiro 2005; Furukawa et al. 2008).
Since each tape-strip removes approximately 1 layer of stratum corneum (i.e. three
sequential tape-strips remove approximately three layers) and based on the average
keratinocyte maturation and differentiation processes for a healthy individual, the measured
total NKA levels reflect dermal exposure that occurred approximately 3–4 weeks prior to
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sampling. Once naphthalene is metabolized into reactive naphthalene-1,2-oxide and the
keratin adduction occurred in the skin, the intermediate reactive metabolites do not go
through the nonenzymatic rearrangement and enter the system circulation as 1NAP or 2NAP
to be further metabolized or excreted. If the individual’s metabolic capacity in the skin
became saturated, excess naphthalene would appear in the blood and enter the systemic
circulation (Kim et al. 2006a, Kim et al. 2006b). Distribution would favor the kidneys due to
the rates of perfusion. Metabolism of naphthalene could occur in the kidney cortex and outer
medulla. Urine 1NAP and 2NAP levels reflect metabolism in both the epidermis and the
kidney and, to a lesser extent, the liver. Exhaled or urine naphthalene levels observed at the
end of the workday reflect the total excess naphthalene in the systemic circulation.
Therefore, the stronger associations for the parent compound (naphthalene) than for
naphthol metabolites in urine suggest that the levels of dermal exposure exceeded the skin’s
capacity to metabolize naphthalene.
The lack of association between the skin NKA levels and the breath naphthalene or urine
naphthol levels is likely due to the fact that the inhalation exposure to jet fuel was
overestimated (75% of the workers uses in-line respirators) and, thus, the relative
contribution of dermal exposure to the systemic exposure was increased. This lack of
association may also be partially due to the differences in the biological half-lives of parent
compound and its metabolites in different tissues/organs, and their representations of
different exposure windows (Ruchirawa et al. 2002). For example, the half-life of
naphthalene in breath is estimated to be 22 min (Egeghy et al. 2003), while half-lives for
urine naphthols are 1.2–4.6 h in a rapid phase, and 14–46 h in a slow phase (Bieniek 1994;
Heikkila et al. 1995).
Our results indicating the lack of correlation between breath and urine biomarkers and skin
protein adducts is supported by previously published studies on various urine biomarkers
and protein adduct levels in regard to PAH exposure. Omland et al. (1994) observed no
correlation between the levels of benzo(a)pyrene-albumin adducts and 1-hydroxypyrene (1-
HP), a urinary biomarker for PAH exposure, in iron foundry workers. No correlation was
observed between 1-HP and DNA or serum protein adducts in traffic police in Bangkok and
Thailand, in Danish foundry workers, in Hungarian aluminum plant workers, or in Danish
bus and postal workers, and garage workers (Sherson et al. 1992; Nielsen et al. 1996; Autrup
et al. 1999; Schoket et al. 1999; Ruchirawa et al. 2002). In addition, in our study the
exposure intensity from one-day measurements may not have represented the exposure that
occurred during the past 20–28 days, as measured by the keratin adduct levels, that the
worker experienced. Therefore, the potential for this lack of correlation was expected.
Using multiple linear regression models in order to consider both environmental and genetic
factors, we observed that the total NKA levels measured in the skin of fuel-cell maintenance
workers were positively associated with exposure duration but inversely associated with the
measured dermal naphthalene level and age. Interestingly, we observed previously that
exposure duration was associated with lower dermal naphthalene level (Chao et al. 2005).
According to our study protocol, the subjects were to work for 4 h and then return to the
examination station at the end of the work shift. Thus, the exposure duration was defined as
the time between starting work and dermal sampling. Due to the lag-time between exposure
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and dermal sampling as well as the relatively fast dermal penetration rate of naphthalene, as
duration of exposure increased, more naphthalene was absorbed into the stratum corneum,
and metabolized by keratinocytes to form keratin adducts. Thus, less naphthalene remained
on the surface of the stratum corneum for sampling by tape-stripping.
Based on the coefficient of age on the total NKA level (−0.019 for all workers and −0.022
for high-exposed group; Table 3), the data suggest an approximate 2% reduction of
naphthalene metabolisms in skin with each year of age increase in this subject population.
This finding is consistent with a 3% reduction in naphthoquinone-albumin adduct level, and
2% reduction in 1,4-benzoquinone-albumin adduct level per year of increase in workers
exposed to PAHs (Rappaport et al. 2002; Waidyanatha et al. 2004b). Experimental evidence
also suggests that percutaneous absorption of some chemicals decrease with increasing age
(Christophers & Kligman 1965; Tagami 1972; Roskos et al. 1989). This change may be due
to the lower water and lipid contents in aged skin compared to young skin, which may
account for decreased skin permeability (Blank & McAuliffe 1985) and partitioning of
exogenous chemicals into the stratum corneum.
Because naphthalene is metabolized by phases I and II enzymes (Buckpitt et al. 2002; Preuss
et al. 2003; Waidyanatha et al. 2004a), we examined the effects of four metabolic genotypes
(CYP2E1, GSTM1, GSTT1, and NQO1) on the measured total NKA levels in the skin and on
the urine biomarker levels (Table 2). We also examined the effects of these genotypes on the
total NKA (Table 3) and the urine naphthalene levels (Table 4) using linear regression
modeling by considering both personal and environmental factors.
Higher levels of DNA adducts and urine naphthols have been observed in GSTM1-null in
comparison to the GSTM1-plus individuals who were exposed to PAHs (Yang et al. 1999;
Lee et al. 2001; Pavanello et al. 2008). However, our results indicated that GSTM1 was not a
significant contributing factor for keratin adduct or urine biomarkers levels (Table 2). In
addition, GSTM1 genotype was not observed to have an effect on dermal exposure, as
measured by keratin adduct levels (Table 3), or systemic dose, as measured by urine
naphthalene levels (Table 4), when other significant factors were accounted for in the
multiple linear regression analyses.
Our results showed that individuals with GSTT1-plus (++/+−) genotype had significantly
higher total NKA levels than the GSTT1-null individuals (p = 0.080) (Table 2). However,
the effects of GSTT1 became insignificant in regard to total NKA levels once other personal
and environmental factors were considered in the linear regression model (Table 3).
Interestingly, GSTT1-plus (++/+−) genotype was negatively associated with the urine
naphthalene levels in the linear regression model (Table 4). No significant association
between GSTT1 genotype and naphthalene metabolism has been observed (Lee et al. 2001;
Nan et al. 2001). In other studies, individuals with GSTT1-null genotype were observed to
have higher risk for benzene toxicity (Wan et al. 2002) and bladder cancer (Hung et al.
2004). On the contrary, Garte et al. (2007) observed a protective effect due to GSTT1-null
genotype in regard to DNA damage. Our results and the conflicting data in the scientific
literature indicate the lack of understanding of the involvement of GST in naphthalene
metabolism and the complexity of investigating individual susceptibility factors in the
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context of environmental/occupational exposure. The effect sizes of the personal and
environmental factors, such as exposure duration and dermal naphthalene level, may
outweigh the effect associated with these metabolic genotypes. A single polymorphism may
have only a weak effect, while susceptibility may be derived from effects of multiple genes,
and the interaction from genes and the environment (Hung et al. 2004).
The second multiple linear regression model showed that urine naphthalene level increased
as the total NKA and post-exposure breath naphthalene levels increased (Table 4). This
observation also suggests that jet fuel exposure was sufficient to saturate the body’s
metabolic capacity since more naphthalene is being excreted without being metabolized.
The induction of CYP2E1 is known to increase the formation of naphthols from
naphthalene, and the polymorphisms in this gene are associated with urine 2NAP levels in
Korean coke oven workers, who were exposed to PAHs via both inhalation and dermal
routes (Wilson et al. 1996; Nan et al. 2001). Therefore, the inverse association between
CYP2E1*6 wild-type (DD) and the urine naphthalene levels was expected. Interestingly, the
same association was not observed in the model constructed with a priori high-exposure
group. It is possible that in the high-exposure group, the metabolic capacity of CYP2E1 had
been reached, which prevented observation of a significant effect of its genotypes on urinary
naphthalene levels in this subject population.
In conclusion, this is the first study to investigate the contribution of both environmental and
genetic factors in regard to the formation of skin keratin adducts and the relationships
between total NKA levels and other JP-8 exposure biomarkers in occupationally exposed
workers. Only naphthalene through dermal route of exposure can induce formation of NKAs
in the skin (i.e. these adducts are route-specific indicators of exposure; inhalation exposure
will not contribute to the formation of these adducts). Therefore, quantitation of naphthyl-
keratin protein adducts in the skin of jet fuel-exposed individuals allows us to investigate the
importance of dermal exposure, penetration, metabolism, and adduction of naphthalene and
to predict more accurately the contribution of chronic dermal exposure to total body burden
for use in exposure assessment models. The total NKA levels were affected by both the
work scenarios and extrinsic and intrinsic personal factors, and were associated with the
urine naphthalene levels, indicating their potential as quantitative biomarkers of dermal
exposure. In addition, this novel dermal exposure biomarker represents the past exposure
that occurred 20–28 days prior to sampling, and can be utilized in exposure assessment for
other common PAHs and environmental pollutants. Further studies are needed in regard to
the relationship between skin NKAs, biological effect markers, and JP-8 health effects to
further explore the potential application of these adducts as biomarkers of naphthalene
exposure and related health effects.
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Table 1
Pearson correlation coefficients (r) between the total skin NKA levels [ln(ng adduct/μg keratin)] and the
exposure and biomarker levels observed in the fuel-cell maintenance workers exposed to jet fuel.
Exposure or biomarker n Pearson correlation (r) p-value
Dermal naphthalene (ng/m2) 105 −0.038 0.704
Pre-exposure breath naphthalene [ln(ng/m3)] 103 0.149 0.133
Post-exposure breath naphthalene (ng/m3) 101 0.038 0.707
Breathing-zone naphthalene [ln(ng/m3)] 100 0.043 0.668
Urine 1NAP [ln(μg/L)] 104 0.080 0.418
Urine 2NAP [ln(μg/L)] 104 0.012 0.907
Total urine naphthols [ln(μg/L)] 104 0.033 0.740
Urine naphthalene [ln(μg/L)] 104 0.184 0.061
Note: n = number of fuel-cell maintenance workers.
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